Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Ascentage Pharma Group International
  6. News
  7. Summary
    6855   KYG0519B1023

ASCENTAGE PHARMA GROUP INTERNATIONAL

(6855)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Ascentage Pharma International : Concludes Issuance of Nearly 7 Million Warrants to Innovent Biologics

10/13/2021 | 06:17am EST


ę MT Newswires 2021
All news about ASCENTAGE PHARMA GROUP INTERNATIONAL
11/30Ascentage Pharma Appoints Former Fosun Pharma Exec as New CFO
MT
11/29Ascentage Pharma Appoints Mr. Yiqing Chen as Chief Financial Officer
PR
11/29Ascentage Pharma Appoints Mr. Yiqing Chen as Chief Financial Officer
CI
11/25Ascentage Pharma Drug Cleared for Leukemia Treatment in China; Shares Fall 8%
MT
11/22European Commission Grants Orphan Drug Designation to Ascentage Pharma's Leukemia Treat..
MT
11/12Ascentage Pharma Buys Back More Shares; Shares Rally 13%
MT
11/11Ascentage Pharma Repurchases More Shares
MT
11/10Ascentage Pharma Buys Back Additional Shares; Stocks Rise 4%
MT
11/08Ascentage Pharma Repurchases More Shares; Shares Gain 3%
MT
11/08Ascentage Pharma, Pfizer to Combine Drugs in Clinical Trial for Breast Cancer Treatment
MT
More news
Financials
Sales 2021 157 M 24,6 M 24,6 M
Net income 2021 -855 M -134 M -134 M
Net Debt 2021 - - -
P/E ratio 2021 -7,87x
Yield 2021 -
Capitalization 6 368 M 999 M 999 M
Capi. / Sales 2021 40,6x
Capi. / Sales 2022 14,5x
Nbr of Employees 531
Free-Float 56,6%
Chart ASCENTAGE PHARMA GROUP INTERNATIONAL
Duration : Period :
Ascentage Pharma Group International Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASCENTAGE PHARMA GROUP INTERNATIONAL
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 24,62 CNY
Average target price 51,83 CNY
Spread / Average Target 110%
EPS Revisions
Managers and Directors
Da Jan Yang Chairman & Chief Executive Officer
Ming Guo President
Yi Qing Chen Chief Financial Officer
Chang Qing Ye Independent Non-Executive Director
Zheng Yi Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
ASCENTAGE PHARMA GROUP INTERNATIONAL-21.82%999
GILEAD SCIENCES, INC.19.40%87 255
BIONTECH SE310.30%83 098
REGENERON PHARMACEUTICALS31.23%66 409
WUXI APPTEC CO., LTD.26.31%65 758
VERTEX PHARMACEUTICALS-13.76%51 819